Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Clorox    CLX

CLOROX (CLX)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

The Clorox Company : Refutes Silent Spring Institute's Study on Our Consumer Products

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2012 | 09:26am EST

We have reviewed the findings of Silent Spring's study claiming some U.S. consumer products contain endocrine-disrupting and asthma-related ingredients.

Product safety is a top priority at The Clorox Company and our company guidelines prohibit using endocrine-disrupting ingredients in our products. For those household products containing fragrance ingredients some consider to be asthma related, these ingredients are present at such low concentrations they do not cause irritation or trigger asthma when used as directed.

Our highly skilled scientists evaluate each product's safety, efficacy and regulatory compliance before it makes it to store shelves. Our safety assessments begin with analysis of each of the materials that go into making the product. This includes consideration of short-term and long-term impact from all types of exposures, including incidental or accidental, and routes of exposure such as skin, eye, ingestion and inhalation. Our safety evaluation also includes the assessment of fragrances, dyes, and preservatives, and other proprietary ingredients, in our formulations.

Clorox voluntarily discloses all ingredients for our U.S. and Canadian household cleaning and disinfecting products through our industry-leading initiative, Ingredients Inside (www.IngredientsInside.com), which is available on our corporate web site and mobile platforms.

For more information on our product stewardship guidelines, visit http://www.thecloroxcompany..


share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CLOROX
02/16ART LOVERS, CAT LOVERS, INSTAGRAM LO : Cats On Glass Gallery Debuts For Limited ..
PR
02/14DAILY DIVIDEND REPORT : Shw, trow, clx, klac, lll, lea
AQ
02/13CLOROX : Increases Quarterly Dividend 14 Percent to 96 Cents Per Share From Tax ..
PR
02/08CLOROX : "Polyelectrolyte Complexes" in Patent Application Approval Process (USP..
AQ
02/08PICTURE THIS : Cats On Glass Gallery Opens For Limited Time In New York
PR
02/07CLOROX : Can Cleaning Make You More Empathetic? New Research Says Yes
PR
02/05CLOROX : Today’s Research Reports on Stocks to Watch: The Clorox Company and Mer..
AC
02/02CLOROX : DE/ Management's Discussion and Analysis of Financial Condition and Res..
AQ
02/02CLOROX (NYSE : CLX) reported earnings of $1.77 per share beating Walls Streets e..
AQ
02/02CLOROX : beats 2Q profit forecasts
AQ
More news
News from SeekingAlpha
02/22My Top 10 Retirement Stocks 
02/22The Market Rewards Customer Satisfaction (Clorox) 
02/2127 DIVIDEND INCREASES : February 12-16, 2018 (Part 3: Remaining Sectors) 
02/21Dividend Companies Showering Shareholders With More Cash 
02/20A New Tool For Dividend Growth Investors 
Financials ($)
Sales 2018 6 122 M
EBIT 2018 1 145 M
Net income 2018 791 M
Debt 2018 1 617 M
Yield 2018 2,70%
P/E ratio 2018 21,02
P/E ratio 2019 19,86
EV / Sales 2018 2,93x
EV / Sales 2019 2,83x
Capitalization 16 342 M
Chart CLOROX
Duration : Period :
Clorox Technical Analysis Chart | CLX | US1890541097 | 4-Traders
Technical analysis trends CLOROX
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 139 $
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Benno O. Dorer Chairman & Chief Executive Officer
Dawn C. Willoughby Chief Operating Officer & Executive VP
Stephen M. Robb Chief Financial Officer & Executive Vice President
Manjit Singh Chief Information Officer & Senior Vice President
Robert W. Matschullat Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
CLOROX-14.41%16 342
UNILEVER INDONESIA TBK PT--.--%30 374
CHURCH & DWIGHT CO-4.44%11 981
LION CORP-4.28%5 881
KOBAYASHI PHARMACEUTICAL CO LTD-5.87%5 349
WD-40 COMPANY7.54%1 773